Global cardiovascular risk management in different Italian regions: An analysis of the evaluation of final feasible effect of control training and ultra sensitisation (EFFECTUS) educational program

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 8, 2012, Pages 635-642

  Tocci, G ^a   Ferrucci, A ^a   Guida, P ^c   Corsini, A ^g   Avogaro, A ^d   Comaschi, M ^h   Cortese, C ^e   Giorda, C B ^j   Manzato, E ^d   Medea, G ^m   Mureddu, G F ^f   Titta, G ^k   Ventriglia, G ^m   Riccardi, G ⁱ   Zito, G B ^l   Volpe, M ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^g UNIVERSITY OF MILAN   (Italy)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^j Metabolism and Diabetes Unit   (Italy)

^k Italian Federation of General Medicine   (Italy)

^l Cardiology Unit   (Italy)

^m Italian Society of General Medicine   (Italy)

more..

Author keywords

Cardiovascular risk management; Diabetes; Educational program; Global cardiovascular risk; Hypercholesterolemia; Hypertension; Survey

Indexed keywords

CARDIOVASCULAR AGENT;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; AWARENESS; CARDIOVASCULAR DISEASE; CHI SQUARE DISTRIBUTION; CLINICAL PRACTICE; CLINICAL TRIAL; COMPARATIVE STUDY; DEMOGRAPHY; EVALUATION; FEASIBILITY STUDY; FEMALE; HEALTH CARE QUALITY; HEALTH PERSONNEL ATTITUDE; HUMAN; ITALY; MALE; MEDICAL EDUCATION; MIDDLE AGED; MULTICENTER STUDY; PRACTICE GUIDELINE; PREVALENCE; PREVENTIVE HEALTH SERVICE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TIME; TREATMENT OUTCOME;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; AWARENESS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; EDUCATION, MEDICAL, CONTINUING; FEASIBILITY STUDIES; FEMALE; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; ITALY; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PREVENTIVE HEALTH SERVICES; PROGRAM EVALUATION; RESIDENCE CHARACTERISTICS; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; TIME FACTORS; TREATMENT OUTCOME;

PHYSCIA;

EID: 84864045316     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.10.009     Document Type: Article

References (29)

1. Lloyd-Jones D., Adams R., Carnethon M., De Simone G., Ferguson T.B., Flegal K., et al. Heart disease and stroke statistics-2009 update: a report from the American heart association Statistics Committee and stroke Statistics Subcommittee. Circulation 2009 Jan 27, 119(3):480-486.
2. Kotseva K., Wood D., De Backer G., De Bacquer D., Pyorala K., Keil U., et al. A survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009 Apr, 16(2):121-137.
3. Kotseva K., Wood D., De Backer G., De Bacquer D., Pyorala K., Keil U. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009 Mar 14, 373(9667):929-940.
4. Gaede P., Lund-Andersen H., Parving H.H., Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008 Feb 7, 358(6):580-591.
5. Gaede P., Vedel P., Larsen N., Jensen G.V., Parving H.H., Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003 Jan 30, 348(5):383-393.
6. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004 Sep 11-17, 364(9438):937-952.
7. Lanas F., Avezum A., Bautista L.E., Diaz R., Luna M., Islam S., et al. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation 2007, 115(9):1067-1074.
8. Nakamura K., Barzi F., Lam T.H., Huxley R., Feigin V.L., Ueshima H., et al. Cigarette smoking, systolic blood pressure, and cardiovascular diseases in the Asia-Pacific region. Stroke 2008, 39(6):1694-1702.
9. Bhatt D.L., Steg P.G., Ohman E.M., Hirsch A.T., Ikeda Y., Mas J.L., et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006, 295(2):180-189.
10. Tocci G., Giovannelli F., Sciarretta S., Ferrucci A., Zito G.B., Volpe M. Management of hypertension and stroke prevention: results of the Italian cardiologist survey. Int J Clin Pract 2009, 63(2):207-216.
11. Volpe M., Tocci G., Avogaro A., Comaschi M., Corsini A., Cortese C., et al. Global cardiovascular risk Assessment in different clinical settings: basal results of the EFFECTUS (Evaluation of final Feasible effect of control Training and Ultra-Sensitisation) Programme. High Blood Press Cardiovasc Prev 2009, 16(2):55-63.
12. Clinical guidelines Expert Panel on the identification, evaluation, and treatment of Overweight in Adults. Am J Clin Nutr 1998, 68(4):899-917. on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary.
13. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. 2007 ESH-ESC practice guidelines for the management of Arterial hypertension: ESH-ESC Task Force on the management of Arterial hypertension. J Hypertens 2007, 25(9):1751-1762.
14. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment Panel III). JAMA 2001, 285(19):2486-2497.
15. Grundy S.M., Brewer H.B., Cleeman J.I., Smith S.C., Lenfant C. Definition of metabolic syndrome: report of the national heart, Lung, and blood Institute/American heart association conference on scientific issues related to definition. Circulation 2004, 109(3):433-438.
16. Ryden L., Standl E., Bartnik M., Van den Berghe G., Betteridge J., de Boer M.J., et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European association for the study of diabetes (EASD). Eur Heart J 2007, 28(1):88-136.
17. Thygesen K., Alpert J.S., White H.D. Universal definition of myocardial infarction. Eur Heart J 2007 , 28(20):2525-2538.
18. Goldstein L.B., Adams R., Alberts M.J., Appel L.J., Brass L.M., Bushnell C.D., et al. Primary prevention of ischemic stroke: a guideline from the American heart Association/American stroke association stroke Council: cosponsored by the Atherosclerotic peripheral vascular disease Interdisciplinary working group; cardiovascular Nursing Council; clinical Cardiology Council; Nutrition, physical Activity, and Metabolism Council; and the Quality of care and Outcomes Research Interdisciplinary working group: the American Academy of Neurology affirms the value of this guideline. Stroke 2006 , 37(6):1583-1633.
19. Wolf-Maier K., Cooper R.S., Kramer H., Banegas J.R., Giampaoli S., Joffres M.R., et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004, 43(1):10-17.
20. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001, 22(7):554-572.
21. Volpe M., Tocci G., Trimarco B., Rosei E.A., Borghi C., Ambrosioni E., et al. Blood pressure control in Italy: results of recent surveys on hypertension. J Hypertens 2007, 25(7):1491-1498.
22. Mancia G., Parati G., Borghi C., Ghironzi G., Andriani E., Marinelli L., et al. Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study. J Hypertens 2006, 24(5):837-843.
23. Borghi C., Dormi A., D'Addato S., Gaddi A., Ambrosioni E. Trends in blood pressure control and antihypertensive treatment in clinical practice: the Brisighella Heart Study. J Hypertens 2004, 22(9):1707-1716.
24. Menotti A., Lanti M., Angeletti M., Botta G., Cirillo M., Laurenzi M., et al. Twenty-year cardiovascular and all-cause mortality trends and changes in cardiovascular risk factors in Gubbio, Italy: the role of blood pressure changes. J Hypertens 2009, 27(2):266-274.
25. Mancia G., Pessina A.C., Trimarco B., Grassi G. Blood pressure control according to new guidelines targets in low- to high-risk hypertensives managed in specialist practice. J Hypertens 2004, 22(12):2387-2396.
26. Verdecchia P., Schillaci G., Reboldi G., Santeusanio F., Porcellati C., Brunetti P. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 2000, 36(6):1072-1078.
27. Cuspidi C., Mancia G., Ambrosioni E., Pessina A., Trimarco B., Zanchetti A. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS). J Hum Hypertens 2004, 18(12):891-896.
28. Mancia G., Facchetti R., Bombelli M., Polo Friz H., Grassi G., Giannattasio C., et al. Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population. Hypertension 2005, 45(6):1072-1077.
29. Palmieri L., Panico S., Vanuzzo D., Ferrario M., Pilotto L., Sega R., et al. [Evaluation of the global cardiovascular absolute risk: the Progetto CUORE individual score]. Ann Ist Super Sanita 2004, 40(4):393-399.